Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial. Issue 2 (1st February 2016) - Karuturi, Meghan; Younes, Anas; Fayad, Luis; Kwak, Larry; Pro, Barbara; Shah, Jatin; Oki, Yasuhiro; Simien, Rinata; Liboon, Mary Joy; Hutto, Toni; Feng, Lei; Horowitz, Sandra; et al.